PT Kimia Farma (Persero) Tbk
Indonesia Stock ExchangeTotal Valuation
PT Kimia Farma (Persero) Tbk carries a market capitalization of 2.50T, placing it among publicly traded companies globally. Its enterprise value stands at 9.98T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.50T |
| Enterprise Value | 9.98T |
Share Statistics
PT Kimia Farma (Persero) Tbk currently has 5.57B shares outstanding.
| Shares Outstanding | 5.57B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.40, and the price-to-book ratio stands at -0.53.
| PE Ratio | N/A |
| PS Ratio | 0.40 |
| PB Ratio | -0.53 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 82.17 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 1.55 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 30.46 |
Financial Position
PT Kimia Farma (Persero) Tbk maintains a current ratio of 0.71, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 237.93, indicating elevated leverage, while an interest coverage ratio of -0.29 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.71 |
| Quick Ratio | 0.07 |
| Debt / Equity | 237.93 |
| Debt / EBITDA | -71.52 |
| Interest Coverage | -0.29 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -0.55 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 446.62 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.81 |
Taxes
Over the trailing twelve months, PT Kimia Farma (Persero) Tbk has paid -10.18B in income taxes, reflecting an effective tax rate of 231.79.
| Income Tax | -10.18B |
| Effective Tax Rate | 231.79 |
Stock Price Statistics
PT Kimia Farma (Persero) Tbk's stock has declined approximately -33.33333% over the past 52 weeks. The 50-day moving average sits at 487.64, while the 200-day moving average is 520.06.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.33333% |
| 50-Day Moving Average | 487.64 |
| 200-Day Moving Average | 520.06 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, PT Kimia Farma (Persero) Tbk generated 6.45T in revenue and converted that into -80.78B in net income, yielding earnings per share of -17.03. EBITDA reached -95.12B, while operating income came in at -95.12B.
| Revenue | 6.45T |
| Gross Profit | 1.44T |
| Operating Income | -95.12B |
| Pretax Income | -95.79B |
| Net Income | -80.78B |
| EBITDA | -95.12B |
| EBIT | -95.12B |
| Earnings Per Share (EPS) | -17.03 |
Balance Sheet
PT Kimia Farma (Persero) Tbk holds 426.62B in cash and equivalents against 6.80T in total debt, resulting in a net debt position of 6.27T. Total book value stands at -4.84T, with working capital of -1.78T providing operational flexibility.
| Cash & Cash Equivalents | 426.62B |
| Total Debt | 6.80T |
| Net Debt | 6.27T |
| Equity (Book Value) | -4.84T |
| Book Value Per Share | -869.75 |
| Working Capital | -1.78T |
Cash Flow
After subtracting -31.30B in capital expenditures, free cash flow totaled -31.30B - equivalent to -5.62 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -31.30B |
| Free Cash Flow | -31.30B |
| FCF Per Share | -5.62 |
Margins
PT Kimia Farma (Persero) Tbk operates with a gross margin of 56.53, reflecting its pricing power and cost economics. The operating margin of -1.48 and net profit margin of -1.25 provide insight into operational efficiency.
| Gross Margin | 56.53 |
| Operating Margin | -1.48 |
| Pretax Margin | -1.49 |
| Profit Margin | -1.25 |
| EBITDA Margin | -1.48 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 6.17 |
| FCF Yield | 1.22 |
Scores
PT Kimia Farma (Persero) Tbk posts an Altman Z-Score of -0.12, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.12 |